Aptamer Group partners with top five global pharmaceutical company to support innovative vaccine development
Partnership includes initial upfront payments and will potentially deliver recurring revenues for over 10 years
Partnership includes initial upfront payments and will potentially deliver recurring revenues for over 10 years
Solutions to complement Company’s growing position in cell and gene therapy research and development
356-patient concordance study confirms performance using head-to-head testing vs. droplet digital PCR
Join us on Tuesday, November 17, to find out how ultra-soft chemical ionization used in SIFT-MS simplifies the analysis of chromatographically challenging volatiles
Digital transformation of the life sciences industry and a push towards precision medicine continues to drive the demand for data
Analytik has launched a range of benchtop time-domain nuclear magnetic resonance (TD-NMR) systems
U.S. approval for MitraClip G4 brings new enhancements to the platform and offers a next-generation approach to mitral valve repair
The company has signed multiple new contracts with leading global PCR manufacturers
Designed to enable easier installation within RABs and filling lines for environmental monitoring in Grade A environments
Partnership will center on Prescient Medicine's novel genetic testing technology designed to objectively assess an individual's risk of opioid addiction